Related Experiment Video
Updated: Feb 19, 2026
05:04
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
Published on: August 9, 2024
1.8K
Pharmacogenomics workshop: a mixed methods evaluation of trainee pharmacist knowledge and skill development, and
Emma Groves1,2, Jessica Keen3,4, Samantha L McLean5
1NHS North East and Yorkshire Genomic Medicine Service Alliance, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne NE1 3BZ, United Kingdom.
The International Journal of Pharmacy Practice
|February 17, 2026
Summary
Pharmacogenomics (PGx) workshops significantly improved UK trainee pharmacists' knowledge but showed gaps in clinical application. Facilitators need better resources for effective PGx training, especially online.
Area of Science:
- Pharmacogenomics Education
- Pharmacy Practice Research
- Healthcare Professional Training
Background:
- Pharmacogenomics (PGx) integration into clinical practice is crucial for personalized medicine.
- Effective training strategies are needed to equip pharmacists with PGx knowledge and skills.
- Understanding the impact of educational interventions on trainee pharmacists is essential.
Purpose of the Study:
- To evaluate a pharmacogenomics (PGx) workshop's effect on UK trainee pharmacists' knowledge, confidence, and clinical application.
- To explore workshop facilitators' experiences and support requirements.
- To identify areas for improvement in PGx education delivery.
Main Methods:
- Mixed-methods study involving pre- and post-workshop surveys for participants.
- Focus groups conducted with workshop facilitators to gather qualitative insights.
- Quantitative data analyzed using descriptive statistics and paired t-tests; qualitative data thematically analyzed.
Main Results:
- Significant increase in trainee pharmacists' self-reported PGx knowledge (P < .01).
- Increased confidence in applying PGx, though not statistically significant (P = .06).
- Facilitators noted challenges with engagement (especially online) and requested better preparatory materials and support.
Conclusions:
- PGx workshops effectively enhance trainee pharmacists' knowledge but highlight persistent gaps in clinical application.
- Facilitator feedback underscores the need for enhanced training resources and support, particularly for online delivery.
- Iterative training sessions and supplementary materials are recommended to solidify PGx knowledge and its practical application.
More Related Videos
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
20
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
20
01:29Pharmacogenomics: Identification of New Drug Targets
20
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
18
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
18
01:27Pharmacogenetics of Drug Metabolism: Overview
23
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
23
01:27Principles of Pharmacogenetics: Types of Genetic Variants
22
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
22
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
24
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24